Eligibility

Not what you're looking for?

About this Trade Mission

Victoria has significant strengths in different areas of research and industry capabilities including infectious disease and diagnostics, cancer, neurology and regenerative medicine with Melbourne a leading location for clinical trials and drug discovery. Melbourne is also a leading location in the Asia-Pacific for new drug candidate identification, medicinal chemistry and drug optimisation as well as clinical trials.

The Victorian Government is keen to showcase these strengths at BIO2016 and is delighted to invite your organisation to express interest in being part of the BIO2016 Victorian delegation.

The Victorian Government will provide your organisation with a variety of marketing opportunities, connection points and networking resources to support your participation at BIO.

What you will get

Pre-conference

Our US Victorian Government Business Office (VGBO) will be closely involved in maximising business opportunities for you.

Opportunities will include:

setting up an e-mail introduction/conference call to discuss your business needs in the market

strategic news and case studies to boost the profile of Victorian organisations through conventional and social media channels.

A Pre-BIO2016 Convention briefing will also be held in Melbourne just prior to departure.

During the conference

The Victorian Government has a dedicated area within the Australian Pavilion. Selected Victorian organisations participating at BIO2016 will have an opportunity to have complimentary logos on the Victorian section of the Australian pavilion.

There will be three informal meeting areas on the Victorian stand open for use by Victorian delegation members. Delegation members may display their marketing material at the Victorian stand. The Victorian Government will plan some targeted networking events and roundtables as well as facilitate invitations to other networking events.

Selected eligible Victorian companies participating in the BIO2016 Trade Mission and with a paid & upgradable BIO convention access registration will be offered access to a biopartnering upgrade (valued at approximately AUD2000). There are a limited number of upgrades and the applications are subject to selection and in particular their alignment to the six focus areas below:

The focus areas are:

infectious disease and diagnostics

cancer

neuroscience

regenerative medicine

new drug development

clinical trials

Post-conference

International companies will be invited to Melbourne to participate in a medtech/pharma Victoria Invitation Program (VIP) that will coincide with the AusBiotech Conference (October 2016). BIO2016 Victorian delegates will be invited to propose their key international contacts to be invited to the VIP.